A maths career in pharma all adds up, says Source Health Economics

Mar 27, 2025

Written by Abby Paine and Jack Scerri

 

What better way to spend a Saturday morning than volunteering to lead an interactive mathematics workshop for a group of enthusiastic young students! That’s exactly what two of our staff did recently when they led a Royal Institution (Ri) Mathematics Masterclass for 50 students aged 13–14 years of age and attending local schools in the Maidenhead area.

Our colleagues, Abby Paine (statistician) and Jack Scerri (health economist) encouraged the students to consider how developing maths and science skills beyond school can open the door to a variety of rewarding careers, including those in medicine. Engaging with the students through a series of games and interactive examples, they demonstrated how statistics, probability, economic and ethical considerations have a fundamental part to play in decision making for health care systems around the world, including for the National Health Service (NHS) in the UK. Using the “Trolley problem” healthcare decision example, the students were encouraged to think through how we not only need ethics for decision making in healthcare, but also mathematics and economics to ensure we make fair decisions.

 

Many of the students were not previously aware that a career in the pharmaceutical industry is an option with qualifications in mathematics and/or economics. Abby and Jack were able to give an insight into some of the rewarding career opportunities available in helping new medicines become available to the people who need them most.

The RI Masterclasses are run by a dedicated team of volunteers, and are designed to encourage and inspire young people in the wide range of applications for mathematics, usually covering concepts that are not taught as part of a school curriculum.

 

If you would like to learn more about how advanced statistics is used to model treatment effects and healthcare costs, please contact Source Health Economics, a HEOR consultancy specialising in evidence generation, health economics, and communication.

More Insights

NICE refines the HST routing criteria: What you need to know

NICE refines the HST routing criteria: What you need to know

Written by Brian O'Toole   The National Institute for Health and Care Excellence (NICE) Highly Specialised Technologies (HST) programme is designed to evaluate innovative treatments for rare and complex conditions. On 19th March ... Read more

Systematic review case study: scoping research to identify comparators

Systematic review case study: scoping research to identify comparators

Written by Sneha Bhadti and David Pritchett   Establishing a list of relevant comparators at the protocol development stage is a vital step in the systematic literature review (SLR) process. Scoping research during this stage can help ... Read more

National Numeracy Day 2025: Why money and maths matter in health economics

National Numeracy Day 2025: Why money and maths matter in health economics

Written by Abby Paine and Dom Partridge This is our third year celebrating National Numeracy Day, and this year’s theme of money is especially relevant for those of us working in health economics and market access. In previous years, ... Read more

Maximising SLRs for HEOR – why PICO matters

Maximising SLRs for HEOR – why PICO matters

Written by Susan O’Connell and Sara Bartlome   Introduction Systematic literature reviews (SLRs) seek to answer a specific research question by translating the question into search terms and developing a literature search strategy to ... Read more